FIP Development Goal 21 [w]

Globally, we will have:

Strategies and systems in place that utilise the workforce to enhance sustainable pharmacy and services. 

Mechanisms

• Academic workforce capacity to conduct pharmacy practice research, outcomes, evaluation processes for sustainability (FIP Development Goal 1 [w]).

• Align workforce education and development strategies with needed integrated services (FIP Development Goal 7 [w]).

• Understand capacity needed to produce and train sufficient workforce members that are available and accessible to ensure continued pharmaceutical care delivery (FIP Development Goal 12 [w]).

• Engage members of the workforce from all sectors in the sustainability discussions and align with workforce policy development (FIP Development Goal 13 [w]).

FIP Development Goal 21 [p]

Globally, we will have:

Policies, regulations and strategies to ensure the sustainability of the environment and minimise the impact of pharmaceuticals and pharmacy practice, but also the appropriate mechanisms to ensure the sustainability of pharmacy practice itself, through appropriate remuneration models for pharmaceutical services.

Mechanisms

• In terms of ecological sustainability, advocate for and contribute to the development and implementation of policies and strategies that recognise, minimise and mitigate the environmental effects of pharmaceuticals and medicines-related practices. This includes the research, development, manufacturing, marketing, distribution, dispensing, use and disposal of medicines; the administrative and legislative processes regulating medicines; all aspects of pharmacy practice; and the education and training of the pharmaceutical workforce for such roles.

• In terms of social, societal and economical sustainability around pharmacy services, advocate for and contribute for the value of pharmaceutical services that ensure equity in access to such services, incentivise their delivery and promote their sustainability and appropriate integration in health care system funding, public or private.

• In terms of social, societal and economical sustainability around pharmacy services, advocate for and contribute for the value of pharmaceutical services that ensure equity in access to such services, incentivise their delivery and promote their sustainability and appropriate integration in health care system funding, public or private.

FIP Development Goal 21 [s]

Globally, we will have:

Scientific strategies and policies in place to maintain consistent supply of medicinal products throughout lifecycle while limiting negative consequences for the environment

Mechanisms

• Collaborate with stakeholders on strategies for environmental monitoring of the impact of pharmaceuticals.

• Promote ecological, social, societal, economical sustainability throughout the life cycle of medical products.